The Aword

  • Increase font size
  • Default font size
  • Decrease font size


E-mail Print PDF


In 1985, Gupta et al. ([1]) published a case history of hydrocephalus and severe spinal adhesive arachnoiditis due to iophendylate, and Kaugars et al. ([2]) wrote about residual cranial contrast.

Meanwhile, a worker at the Drug and Poison Information Control wrote to Alcon reporting a case of paralysis in the lower extremities, also sending a copy to the FDA.

The complaint was referred on within the FDA after several months, but what action, if any, was taken is not apparent.

[1] Gupta SR, Naheedy MH, O'Hara RJ, Rubino FA. Comput Radiol 1985 Nov-Dec; 9(6): 359-64 Hydrocephalus following iophendylate injection myelography with spontaneous resolution: case report and review.


[2] Kaugars GE, Campbell RL, Shulman J. Oral Surg Oral Med Oral Pathol 1985 Dec; 60(6): 679-81 Residual intracranial contrast agent.